# ImmuneID funding: rounds and investors

> ImmuneID has raised $50M across 1 round since 2021. Investors include ARCH Venture Partners, S32 and Longwood Fund. Every round with its source.

Source: https://millionrounds.com/company/immuneid (Millionrounds; every figure on the page links to its filing or article)

[Series A startup](https://millionrounds.com/companies)

# Who invested in *ImmuneID*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$50M** raised across 1 round since 2021, from 1 source

- **Latest round:** Series A, $50M Jun 2021
- **Investors:** 4

See who backed them

## The rounds

- **Jun 2021** Series A **$50M** [ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) [S32](https://millionrounds.com/fund/s32) [Longwood Fund](https://millionrounds.com/fund/longwood-fund) Pitango VC Source recorded

## Everyone who backed them

[ARCH Venture Partners](https://millionrounds.com/fund/arch-venture-partners) VC firm **1** round

[S32](https://millionrounds.com/fund/s32) VC firm **1** round

[Longwood Fund](https://millionrounds.com/fund/longwood-fund) VC firm **1** round

Pitango VC no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=immuneid).

## Quick answers about ImmuneID

### Who invested in ImmuneID?

ImmuneID's investors include ARCH Venture Partners, S32, Longwood Fund and Pitango VC.

### How much has ImmuneID raised?

ImmuneID has raised $50M across 1 round since 2021.

### When did ImmuneID last raise?

ImmuneID's most recent round was a Series A of $50M in Jun 2021.

### What was ImmuneID's biggest round?

Its most recent round, $50M in Jun 2021, is also its largest on record.

### Who backed ImmuneID first?

ImmuneID's first round on record, in Jun 2021, was backed by ARCH Venture Partners, S32 and Longwood Fund and 1 others.

### What stage is ImmuneID at?

ImmuneID's latest named round is a Series A, in Jun 2021.

## Companies like ImmuneID

In the same sector, and raised in the last eighteen months.

[**Cloverleaf Bio** $33M · Sept 2026](https://millionrounds.com/company/cloverleaf-bio)[**Cheiron** $8.0M · Jul 2026](https://millionrounds.com/company/cheiron)[**Tavo Biotherapeutics** $17M · Jun 2026](https://millionrounds.com/company/tavo-biotherapeutics)[**Countable Labs** $26M · May 2026](https://millionrounds.com/company/countable-labs)[**Oricell Therapeutics** $180M · Apr 2026](https://millionrounds.com/company/oricell-therapeutics)[**Immunofoco** $29M · Mar 2026](https://millionrounds.com/company/immunofoco)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app
